Trials / Completed
CompletedNCT03820388
Comparison of Etomidate Plus Propofol, Etomidate Alone on Induction of Anesthesia
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 75 (actual)
- Sponsor
- University of California, Davis · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Comparison of Etomidate plus Propofol vs. Propofol or Etomidate alone during induction of anesthesia.
Detailed description
Comparison of Etomidate plus Propofol vs. Propofol or Etomidate alone during induction of anesthesia. The specific aims are testing patient reactions during induction, and in the post-anesthesia care unit (PACU).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Propofol 2mg/kg | 2 mg/kg |
| DRUG | Etomidate 0.3 mg/kg | 0.3 mg/kg |
| DRUG | Propofol 1 mg/kg | 1 mg/kg Propofol |
| DRUG | Etomidate 0.15 mg/kg | 0.15 mg/kg Etomidate |
Timeline
- Start date
- 2017-12-01
- Primary completion
- 2018-07-13
- Completion
- 2018-07-13
- First posted
- 2019-01-29
- Last updated
- 2021-02-23
- Results posted
- 2021-02-23
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03820388. Inclusion in this directory is not an endorsement.